January 25, 2021 News Antigen test available on Simoa HD-X Analyzer® intended for qualitative detection of the nucleocapsid protein (N protein) from SARS-CoV-2 in nasopharyngeal swab specimens You Might Also Like Fluidigm and SIgN Establish the First Center of Excellence in Singapore to Advance Imaging Mass Cytometry March 12, 2020 Mission Bio launches first commercial high-throughput cell therapy assay for measuring vector copy number October 8, 2022 Big step towards expanding into the South East Asia market as Navinci and Everlife-Research Instruments announce a strategic partnership November 14, 2023
Fluidigm and SIgN Establish the First Center of Excellence in Singapore to Advance Imaging Mass Cytometry March 12, 2020
Mission Bio launches first commercial high-throughput cell therapy assay for measuring vector copy number October 8, 2022
Big step towards expanding into the South East Asia market as Navinci and Everlife-Research Instruments announce a strategic partnership November 14, 2023